Hanover Bancorp director awarded 1,592 shares

Hanover Bancorp, Inc. director Michael David Katz, M.D. reported receiving a grant of 1,592 shares of common stock on February 5, 2026 at a price of $0.0000 per share.

Rhea-AI Filing Summary

Hanover Bancorp, Inc. director Michael David Katz, M.D. reported receiving a grant of 1,592 shares of common stock on February 5, 2026 at a price of $0.0000 per share. These restricted shares are subject to forfeiture and vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

After this grant, he directly holds 152,202 common shares, and also has indirect holdings of 25 shares as custodian for Grandchild #1, 40 shares as custodian for Grandchild #2, and 96,760 shares as beneficiary of a trust.

Insider Trade Summary

Grant/Award: 1,592 shares

Grant/Award 4 txns

Insider Katz Michael David M.D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,592	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 152,202 shares (Direct); Common Stock — 25 shares (Indirect, By Custodian for Grandchild #1); Common Stock — 40 shares (Indirect, By Custodian for Grandchild #2); Common Stock — 96,760 shares (Indirect, By Trust - Beneficiary)

Footnotes (1)

1. F1. Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Hanover Bancorp (HNVR) director Michael David Katz report?

He reported receiving a grant of 1,592 Hanover Bancorp common shares on February 5, 2026. The grant is in the form of restricted stock, awarded at $0.0000 per share as part of his equity compensation.

How many Hanover Bancorp shares were granted to Michael David Katz in this Form 4?

The Form 4 discloses a grant of 1,592 shares of Hanover Bancorp common stock. These shares are restricted stock subject to vesting conditions and forfeiture, rather than immediately unrestricted, freely tradable shares.

What are the vesting terms of Michael David Katz’s restricted Hanover Bancorp shares?

The 1,592 restricted shares vest over three years, one-third on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Until vested, the shares remain subject to forfeiture conditions.

How many Hanover Bancorp shares does Michael David Katz own directly after this grant?

Following the reported transaction, Michael David Katz directly owns 152,202 Hanover Bancorp common shares. This figure reflects his direct holdings after adding the 1,592-share restricted stock grant disclosed in the Form 4 filing.

What indirect Hanover Bancorp holdings are reported for Michael David Katz?

He reports indirect ownership of 25 Hanover Bancorp shares as custodian for Grandchild #1, 40 shares as custodian for Grandchild #2, and 96,760 shares as beneficiary of a trust. These positions are separate from his direct 152,202-share holding.

Was the Hanover Bancorp restricted stock grant to Michael David Katz a cash purchase?

No, the grant was not a cash purchase; it is reported at a price of $0.0000 per share. This indicates it is an equity award, typically provided as part of director compensation rather than bought in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 02:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Katz Michael David M.D.

(Last) (First) (Middle)

C/O HANOVER BANCORP, INC.

80 EAST JERICHO TURNPIKE

(Street)

MINEOLA NY 11501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hanover Bancorp, Inc. /MD [ HNVR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/05/2026		A		1,592(1)	A	$0.0000	152,202	D
Common Stock								25	I	By Custodian for Grandchild #1
Common Stock								40	I	By Custodian for Grandchild #2
Common Stock								96,760	I	By Trust - Beneficiary

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ Michael David Katz M.D.	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.